These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3276193)

  • 21. Does the hygroscopic property of the laminaria tent imply a risk for ascending infection in legal abortions? A microbiological study.
    Evaldson GR; Fianu S; Jonasson A; Larsson B; Nord CE; Olund AR
    Acta Obstet Gynecol Scand; 1986; 65(3):257-61. PubMed ID: 3739632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing febrile complications of suction curettage abortion.
    Park TK; Flock M; Schulz KF; Grimes DA
    Am J Obstet Gynecol; 1985 Jun; 152(3):252-5. PubMed ID: 4003471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion.
    Durlot F; Dubois C; Brunerie J; Frydman R
    Hum Reprod; 1988 Jul; 3(5):583-4. PubMed ID: 3170699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postabortal infectious morbidity after antibiotic treatment of chlamydia-positive patients.
    Osser S; Persson K
    Sex Transm Dis; 1989; 16(2):84-7. PubMed ID: 2740963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pelvic infection after elective abortion associated with Chlamydia trachomatis.
    Møller BR; Ahrons S; Laurin J; Mårdh PA
    Obstet Gynecol; 1982 Feb; 59(2):210-3. PubMed ID: 7078867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlamydia trachomatis: is it possible to reduce the number of infections after abortions?
    Skjeldestad FE; Dalen A
    Scand J Prim Health Care; 1988 May; 6(2):125-8. PubMed ID: 3387707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morbidity risk among young adolescents undergoing elective abortion.
    Burkman RT; Atienza MF; King TM
    Contraception; 1984 Aug; 30(2):99-105. PubMed ID: 6499441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for cervical Chlamydia trachomatis infections in two Dutch populations.
    Thewessen EA; van der Meijden WI; Doppenberg HJ; Mulder PG; Wagenvoort JH; Stolz E; Michel MF
    Genitourin Med; 1990 Oct; 66(5):361-6. PubMed ID: 2245984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of damage to the cervix by dilatation for first-trimester-induced abortion by suction aspiration.
    Molin A
    Gynecol Obstet Invest; 1993; 35(3):152-4. PubMed ID: 8505006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind randomized study of the effect of erythromycin in preventing pelvic inflammatory disease after first trimester abortion.
    Sørensen JL; Thranov I; Hoff G; Dirach J; Damsgaard MT
    Br J Obstet Gynaecol; 1992 May; 99(5):434-8. PubMed ID: 1622919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A five-year experience with second-trimester induced abortions: no increase in complication rate as compared to the first trimester.
    Jacot FR; Poulin C; Bilodeau AP; Morin M; Moreau S; Gendron F; Mercier D
    Am J Obstet Gynecol; 1993 Feb; 168(2):633-7. PubMed ID: 8438943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy.
    Ngai SW; Tang OS; Lao T; Ho PC; Ma HK
    Hum Reprod; 1995 May; 10(5):1220-2. PubMed ID: 7657769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis.
    Sawaya GF; Grady D; Kerlikowske K; Grimes DA
    Obstet Gynecol; 1996 May; 87(5 Pt 2):884-90. PubMed ID: 8677129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised controlled trial of prophylaxis of post-abortal infection: ceftriaxone versus placebo.
    Henriques CU; Wilken-Jensen C; Thorsen P; Møller BR
    Br J Obstet Gynaecol; 1994 Jul; 101(7):610-4. PubMed ID: 8043540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of infection after induced abortion: release date October 2010: SFP guideline 20102.
    Achilles SL; Reeves MF;
    Contraception; 2011 Apr; 83(4):295-309. PubMed ID: 21397086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mobiluncus and clue cells as predictors of PID after first-trimester abortion.
    Larsson PG; Bergman B; Forsum U; Platz-Christensen JJ; Påhlson C
    Acta Obstet Gynecol Scand; 1989; 68(3):217-20. PubMed ID: 2618604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
    N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic.
    Magder LS; Harrison HR; Ehret JM; Anderson TS; Judson FN
    Am J Epidemiol; 1988 Aug; 128(2):298-308. PubMed ID: 3394697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genital infections in women undergoing therapeutic abortion.
    Avonts D; Piot P
    Eur J Obstet Gynecol Reprod Biol; 1985 Jul; 20(1):53-9. PubMed ID: 4029474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications of abortion performed under local anesthesia.
    Thonneau P; Fougeyrollas B; Ducot B; Boubilley D; Dif J; Lalande M; Soulat C
    Eur J Obstet Gynecol Reprod Biol; 1998 Oct; 81(1):59-63. PubMed ID: 9846716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.